Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

November 1, 2026

Conditions
Benign Paroxysmal Positional Vertigo
Interventions
PROCEDURE

Group A

Acupoint selection: The location of the vertigo-auditory area follows the positioning standard of Jiao Shunfa's Head Acupuncture. Operation: Electroacupuncture stimulation in the vertigo-auditory area of affected side. Pulse electrotherapy produced by Wujin Changcheng Medical Instrument. Sparse-dense waveforms are selected, with a voltage of 2-4V, a frequency of 60-80 times/min, and the intensity is determined by the patient's tolerance. The needle is in affected side for 30 minutes, and treatment is given once daily for a total of 5 days.

DRUG

Group B

"The original text is related to a medication called Pitavastatin Calcium Tablets, commonly known as Minshilang in Chinese, produced by Weicai (China) Pharmaceutical Co., Ltd. The dosage is 12mg, three times a day (Tid) for four consecutive weeks. Compliance monitoring is conducted by counting the remaining tablets in the medication packaging box brought by patients during the 4-week follow-up period. Concurrent use of other medications that may affect the observation results, such as anti-anxiety drugs, vestibular suppressants, and anti-dizziness Chinese patent medicines, is considered a violation of the protocol."

Trial Locations (1)

Unknown

RECRUITING

Xi'an No3 Hospital, Xi'an

All Listed Sponsors
lead

Xi'an No.3 Hospital

OTHER_GOV